Elevance Health, Inc. (ELV) News
Latest headlines that mention ELV, newest first · each headline opens the original publisher
- Last price
- $434.13
- Day change
- -1.37%
- Next earnings
- —
ELV headlines
last 30 daysClinical efficiency gains and integrated pharmacy benefits are lengthening the runway for margin expansion beyond 2026.
CEO Boudreaux raised full-year guidance on Medicaid improvements and Carelon momentum.
For the third quarter, the health-insurance company reported a rise in net income to $1.34 billion, or $6.27 a share, compared with $1.19 billion, or $5.32 a share, a year earlier.
Elevance Health Inc. raised its full-year profit guidance after a better-than-expected third quarter and signaled earnings next year would top current Wall Street estimates, a sign of growing confidence as the healthcare giant rebuilds profits in its insurance business.
Nutex Health and Elevance Health may be underpriced, despite their share growth this year.
Also mentioned with ELV
30d
Headlines that tag both tickers
ELV news alerts
Get an alert by email or push when a new headline mentions ELV.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.